CCR7 and breast cancer: Activation of CCR4 and CCR7 by their respective chemokine ligands CXCL12, CCL19/CCL21 downregulates pro-apoptotic Bmf and upregulates pro-survival proteins Bcl-2 and Bcl-xL, specifically reducing the sensitivity of metastatic BC cells to anoikis [205].